Ameet Nathwani rebounds from Sanofi purge to helm Dewpoint; Ali Mortazavi named CEO at e-therapeutics
→ Sanofi vet Ameet Nathwani has joined Arie Belldegrun and ARCH Venture Partners-backed Dewpoint Therapeutics as its new CEO. During his tenure at Sanofi, Nathwani served as CMO, chief digital officer and executive committee member. Prior to that, Nathwani completed a 12-year stint at Novartis, where he held roles such as global head of the critical care business franchise and SVP and global development head of the cardiovascular and metabolism franchise.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 109,900+ biopharma pros reading Endpoints daily — and it's free.